AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

AHA 2022 Conference Coverage

N. Marston

ACC 2023: Management of Statin Side Effects and How to Keep Them on …

ACC 2023 Conference Coverage

J. Saseen

Coronary Calcium Score as a Tool to Assist in Decision Making for Pr…

Preventative Cardiology Forum XXXIV

M. Saleh

The 'Familial' in Familial Hypercholesterolemia

Samuel Gidding

Big Questions About Lipoprotein “Little” (a)

MUSC Cardiology

A. Arana Waring

ACC 2024 Insights: Measure Lp(a) in All Patients Once: One & Done!

ACC 2024 Insights

S. Mora

Natural Options for Blood Sugar: What’s the Evidence?

Integrative Medicine - Astrid Pujari

A. Pujari

Lipids Update: Overview of Current Guidelines for Lipid Management

Scripps Health

D. Cork

Inclisiran as a Lipid-Lowering Therapy

Dimitri Richter

New(er) Options for Treating Dyslipidemia

San Diego Heart Failure Symposiums

H. Bhatia

HDL-C: Helpful, Harmful, Hopeful, or Guilty by Association?

Heart in Diabetes (HiD)

L. Sperling

Beyond Statins: State of the Art Treatment for Severe Lipid Disorders

MonteHeart Imaging & Clinical Lectures

E. Gianos

A Practical Approach to LDL and TG-Related Risk Management

Canadian Collaborative Research Network

R. Hegele

Who Is Appropriate for PCSK-9 Inhibitors, Including Inclisiran?

Penn Medicine Heart and Vascular Center

A. Bajaj

AAIC 2024 Insights: Association of High Density Lipoprotein Choleste…

AAIC 2024 Insights Hub

A. Saeed

LP(a) in Primary Prevention is Actionable Today

The American Society for Preventive Cardiology

V. Bittner